India

FDA
Manufacturing

India's Aspen Biopharma Labs hit with FDA warning letter

Aspen Biopharma Labs was hit with a warning letter from the FDA outlining multiple issues at its drug ingredients manufacturing facility in India.
Joseph Keenan Mar 26, 2025 1:09pm
gene therapy AAV adeno-associated viruses

Bharat makes $75M cell and gene therapy splash: reports

Mar 24, 2025 9:01am
FDA

Granules hit with FDA warning letter over production woes

Mar 5, 2025 8:38am
inspection investigation FDA FDA inspection

FDA hits Piramal with 6-observation Form 483 at India API plant

Feb 26, 2025 10:22am
FDA

FDA hits 2 Indian API makers with warning letters, import alerts

Feb 20, 2025 9:05am
Aragen

Aragen snares $100M investment to expand its operations

Jan 14, 2025 7:50am